Thursday, March 23, 2023 Current Time : 1:51 in Tehran
Created Date : Tuesday, August 24, 2021   Update Date : Monday, January 3, 2022    Visit : 777


Dr. Aida Adlimoghaddam

Research Associate, Senior Scientist


St. Boniface Hospital Research Centre, Division of Neurodegenerative Disorders

University of Manitoba, Canada


E-mail Address:

Phone: +1 (204) 2353206

Address: 351 Tache Ave, Winnipeg, Manitoba, Canada R2H 2A6



Dr. Aida Adlimoghaddam is a research associate at St. Boniface Hospital Research Centre – Division of Neurodegenerative Disorders, in Winnipeg, Manitoba, Canada. She obtained her Ph.D. in Biological Sciences from the University of Manitoba in 2015. Following her doctoral research, she was awarded a very competitive Postdoctoral Fellowship in the Department of Pharmacology and Therapeutics at the University of Manitoba. She has been honored to receive a number of prestigious awards including a young investigator drug discovery foundation (ADDF) Award.

Dr. Adlimoghaddam has engaged in teaching and research across various disciplines, for nearly 15 years. She earned her expertise through years of hard work, networking and collaboration with academic and industrial partners at local, national, and international levels. Dr. Adlimoghaddam has taught/mentored secondary, undergraduate and graduate students; published over 20 manuscripts in high impact journals; provided nearly 40 oral and poster presentations at various conferences, meetings, and community outlets (radio, television, and YouTube interviews).

As a major component of her doctoral program, Dr. Adlimoghaddam tested the effect of various pharmaceuticals, such as: acetazolamide, colchicine, concanamycin C, ouabain, phenamil, amiloride, and 5-(N-ethyl-N-isopropyl) amiloride (EIPA) to investigate and characterize the function of various ion channels in C. elegans and human cell lines. Following her doctoral research, she has overseen a variety of projects related to mitochondrial dysfunction, inflammatory processes, learning, and memory in Alzheimer’s disease. She has utilized a wide range of pharmaceuticals and dietary interventions in Alzheimer’s disease to determine if these compounds differently improve mitochondrial function, memory, or inflammatory processes in Alzheimer’s disease vs. control.


Research Priorities:

  • Neurobiology of memory and its impairments
  • Repurposing drugs for the treatment of neurodegenerative disorders
  • Identifying the molecular signaling pathways and mechanisms that could be targeted with therapeutics for preventing memory deficits in Alzheimer’s disease and other type of dementia
  • Regulation of mitochondrial bioenergetics and biogenesis via the autophagy pathway(s) in Alzheimer’s brain